References
- Olley P, Coceani F. Use of prostaglandins in cardiopulmonary diseases of the newborn. Prostaglandins in the Perinatal Period, M A Heymann. Grune and Statton, New York 1980; 135–42
- Gorman R R, Marcus A J. Prostaglandins and cardiovascular disease. Current Concepts, Kalamazoo. Upjohn, Mich 1981
- Issekutz A C, Movat H Z. The effect of vasodilator prostaglandins on polymorphonuclear leukocyte infiltration and vascular injury. Am J Pathol 1982; 107: 300–9
- Heffelfinger S, Hawkins E P, Nihill M, Langston C. Pulmonary vascular changes associated with prolonged prostaglandin El treatment. Pediatr Pathol 1987; 7: 165–73
- Ringel R E, Brenner J I, Haney P J, Burns J E, Moulton A L, Berman M A. Prostaglandin-induced periostitis: A complication of long-term PGE1 infusion in an infant with congenital heart disease. Radiology 1982; 142: 657–8
- Snyder D S, Beller D I, Unanue E R. Prostaglandins modulate macrophage la expression. Nature 1982; 299: 163–5
- Snyder D S, Lu C Y, Unanue E R. Control of macrophage la expression in neonatal mice: Role of a splenic suppressor cell. J Immunol 1982; 128: 1458–65
- Oliveira M C, Pinto e Silva P, Orsi A M, Dias S M. Anatomical closure of the ductus arteriosus in the dog (Cams familians). Acta Anat 1979; 104: 319–22
- Gittenberger-de Groot A C, Strengers J L, Mentink M, Poelmann R E, Patterson D F. Histologic studies on normal and persistent ductus arteriosus in the dog. J Am Coll Cardiol 1985; 6: 394–404